Prognostic impact of using drug-eluting-stents on outcome and strategy in multivessel PCI: Data from the Frankfurt MV-PCI registry

Journal of Cardiology

Volumn 61, Issue 1, 2013, Pages 38-43

  Schwietz, Thomas ^a   Ehrlich, Joachim R ^a   De Rosa, Salvatore ^a   Fichtlscherer, Stephan ^a   Schächinger, Volker ^a   Baier, Gregor ^a   Laskowski, Rafael ^a   Zeiher, Andreas M ^a   Spyridopoulos, Ioakim ^a   Lehmann, Ralf ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Drug eluting stent; Long term survival; Multivessel percutaneous coronary intervention

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BARE METAL STENT; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVESSEL PERCUTANEOUS CORONARY INTERVENTION; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872383894     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.08.008     Document Type: Article

References (17)

1. Vink M.A., Dirksen M.T., Suttorp M.J., Tijssen J.G., van Etten J., Patterson M.S., Slagboom T., Kiemeneij F., Laarman G.J. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial. JACC Cardiovasc Interv 2011, 4:24-29.
2. Jensen J., Lagerqvist B., Aasa M., Sarev T., Nilsson T., Tornvall P. Clinical and angiographic follow-up after coronary drug-eluting and bare metal stent implantation. Do drug-eluting stents hold the promise?. J Intern Med 2006, 260:118-124.
3. Jensen L.O., Maeng M., Thayssen P., Kaltoft A., Tilsted H.H., Bottcher M., Lassen J.F., Hansen K.N., Krusell L.R., Rasmussen K., Pedersen K.E., Pedersen L., Paaske Johnsen S., Sørensen H.T., Thuesen L. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction. Circ Cardiovasc Interv 2008, 1:176-184.
4. Lemos P.A., Serruys P.W., van Domburg R.T., Saia F., Arampatzis C.A., Hoye A., Degertekin M., Tanabe K., Daemen J., Liu T.K., McFadden E., Sianos G., Hofma S.H., Smits P.C., van der Giessen W.J., et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the " real world" : the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 2004, 109:190-195. [Epub 2003/12/24].
5. Nordmann A.J., Briel M., Bucher H.C. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 2006, 27:2784-2814.
6. Wilson W.M., Andrianopoulos N., Clark D., Duffy S.J., Brennan A., Harries I., New G., Sebastian M., Loane P., Reid C., Ajani A.E. Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stents. Am J Cardiol 2011, 108:936-942.
7. Takayama T., Hiro T., Hirayama A. Stent thrombosis and drug-eluting stents. J Cardiol 2011, 58:92-98.
8. Ishikawa T., Mutoh M., Nakano Y., Endo A., Kubota T., Suzuki T., Nakata K., Murakami A., Miyamoto T., Sakamoto H., Okada H., Imai K., Yoshimura M. Retrospective comparison of clinical and angiographic outcomes after primary stenting using sirolimus-eluting and bare-metal stents in nonrandomized consecutive 568 patients with first ST-segment elevated myocardial infarctions. J Cardiol 2011, 57:44-52.
9. Lagerqvist B., James S.K., Stenestrand U., Lindback J., Nilsson T., Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007, 356:1009-1019.
10. Serruys P.W., Daemen J. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Circulation 2007, 115:1433-1439.
11. Camenzind E., Steg P.G., Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 2007, 115:1440-1455.
12. Mauri L., Silbaugh T.S., Wolf R.E., Zelevinsky K., Lovett A., Zhou Z., Resnic F.S., Normand S.L. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation 2008, 118:1817-1827.
13. Mauri L., Silbaugh T.S., Garg P., Wolf R.E., Zelevinsky K., Lovett A., Varma M.R., Zhou Z., Normand S.L. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008, 359:1330-1342.
14. Nakagawa T., Hiasa Y., Hosokawa S., Minami T., Yano Y., Yoneda K., Mizobe M., Murakami N., Tobetto Y., Chen H., Miyazaki S., Mahara K., Ogura R., Miyajima H., Yuba K., et al. The potential benefits and risks of the use of dual antiplatelet therapy beyond 6 months following sirolimus-eluting stent implantation for low-risk patients. J Cardiol 2011, 57:283-289.
15. Ho H.H., Pong V., Siu C.W., Jim M.H., Miu R., Yiu K.H., Ko R., Tse H.F., Kwok O.H., Chow W.H. Long-term clinical outcomes of drug-eluting stents vs bare-metal stents in Chinese patients. Clin Cardiol 2010, 33:E22-E29.
16. Lehmann R., Fichtlscherer S., Schachinger V., Held L., Hobler C., Baier G., Zeiher A.M., Spyridopoulos I. Favorable long-term survival in patients undergoing multivessel-PCI compared to predicted prognosis of CABG estimated by EuroSCORE: procedural and clinical determinants of long-term outcome. J Intervent Cardiol 2009, 22:511-519.
17. Lehmann R., Fichtlscherer S., Schachinger V., Held L., Hobler C., Baier G., Zeiher A.M., Spyridopoulos I. Complete revascularization in patients undergoing multivessel PCI is an independent predictor of improved long-term survival. J Intervent Cardiol 2010, 23:256-263.